Please assess the completion status of the following clinical trial:

Trial Title: A Study of DU-176b in Preventing Blood Clots After Hip Replacement Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: None

Eligibility Criteria:
1. 18 years of age or older; male or female.~2. Able to provide written informed consent.~3. Must be scheduled for elective unilateral total hip replacement surgery. Only primary surgeries accepted.~4. If female, must be either one year post-menopausal, surgically sterile, or using medically accepted contraceptive measures as judged by the Investigator and in accordance with local regulatory requirements.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).